Vanguard Group
LFST icon

Vanguard Group’s Lifestance Health LFST Stock Holding History

Vanguard Group’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$125M Buy
17,700,041
+3,086,506
+21% +$18.6M ﹤0.01% 1774
2025
Q3 		$80.4M Buy
14,613,535
+2,383,728
+19% +$11.7M ﹤0.01% 1947
2025
Q2 		$63.2M Buy
12,229,807
+1,008,570
+9% +$6.04M ﹤0.01% 2024
2025
Q1 		$74.7M Buy
11,221,237
+531,841
+5% +$4.04M ﹤0.01% 1922
2024
Q4 		$78.8M Buy
10,689,396
+784,818
+8% +$5.63M ﹤0.01% 1964
2024
Q3 		$69.3M Buy
9,904,578
+655,082
+7% +$3.94M ﹤0.01% 2046
2024
Q2 		$45.4M Buy
9,249,496
+1,580,530
+21% +$9.53M ﹤0.01% 2187
2024
Q1 		$47.3M Buy
7,668,966
+95,197
+1% +$641K ﹤0.01% 2195
2023
Q4 		$59.3M Buy
7,573,769
+48,574
+0.6% +$313K ﹤0.01% 2113
2023
Q3 		$51.7M Buy
7,525,195
+84,373
+1% +$684K ﹤0.01% 2123
2023
Q2 		$67.9M Buy
7,440,822
+203,329
+3% +$1.69M ﹤0.01% 2052
2023
Q1 		$53.8M Buy
7,237,493
+162,680
+2% +$902K ﹤0.01% 2144
2022
Q4 		$34.9M Buy
7,074,813
+80,680
+1% +$499K ﹤0.01% 2346
2022
Q3 		$46.3M Buy
6,994,133
+832,246
+14% +$5.81M ﹤0.01% 2222
2022
Q2 		$34.3M Sell
6,161,887
-41,043
-0.7% -$314K ﹤0.01% 2375
2022
Q1 		$62.7M Buy
6,202,930
+2,749,277
+80% +$24.1M ﹤0.01% 2196
2021
Q4 		$32.9M Buy
3,453,653
+63,198
+2% +$670K ﹤0.01% 2576
2021
Q3 		$49.2M Buy
3,390,455
+737,302
+28% +$14.2M ﹤0.01% 2370
2021
Q2 		$73.9M Buy
+2,653,153
New +$70.1M ﹤0.01% 2162

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group's LFST Position: Q4 2025 in Review

Vanguard Group increased its Lifestance Health (LFST) stake by 21% in Q4 2025, buying an estimated $18.6M and bringing the position to 17,700,041 shares worth $125M. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Vanguard Group first reported a position in LFST in Q2 2021 and has held it in 19 quarters since. 204 funds tracked by Wall St. Rank hold LFST as of Q4 2025.

  • Vanguard Group held 17,700,041 shares of Lifestance Health worth $125M as of Q4 2025.
  • Vanguard Group bought 3,086,506 Lifestance Health shares in Q4 2025, an estimated $18.6M.
  • Lifestance Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1774 holding.
  • Vanguard Group first reported a position in Lifestance Health in Q2 2021 and has held it in 19 quarters since.
  • 204 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.